Roy Baynes

759 total citations
20 papers, 604 citations indexed

About

Roy Baynes is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Roy Baynes has authored 20 papers receiving a total of 604 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 7 papers in Oncology and 6 papers in Genetics. Recurrent topics in Roy Baynes's work include Iron Metabolism and Disorders (8 papers), Immunotherapy and Immune Responses (4 papers) and Hemoglobinopathies and Related Disorders (4 papers). Roy Baynes is often cited by papers focused on Iron Metabolism and Disorders (8 papers), Immunotherapy and Immune Responses (4 papers) and Hemoglobinopathies and Related Disorders (4 papers). Roy Baynes collaborates with scholars based in South Africa and United States. Roy Baynes's co-authors include T. H. Bothwell, Roger Dansey, W.R. Bezwoda, Gary S. Wood, Chatchada Karanes, W. R. Bezwoda, Jared Klein, J Kallenbach, Andrew E. Sloan and Geoffrey Barger and has published in prestigious journals such as The Lancet, Clinical Infectious Diseases and The American Journal of Medicine.

In The Last Decade

Roy Baynes

20 papers receiving 586 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roy Baynes South Africa 13 294 189 145 140 107 20 604
R. W. Martell South Africa 13 334 1.1× 178 0.9× 45 0.3× 153 1.1× 70 0.7× 32 657
K A Deubelbeiss Switzerland 7 374 1.3× 225 1.2× 155 1.1× 297 2.1× 127 1.2× 7 935
A J Eerenberg-Belmer Netherlands 12 203 0.7× 175 0.9× 58 0.4× 312 2.2× 59 0.6× 16 591
J Kerbauy Brazil 14 468 1.6× 334 1.8× 68 0.5× 61 0.4× 99 0.9× 55 700
Robert S. Negrin United States 9 551 1.9× 177 0.9× 205 1.4× 279 2.0× 110 1.0× 11 785
B. Justiça Portugal 17 386 1.3× 361 1.9× 118 0.8× 328 2.3× 39 0.4× 38 806
Rosa Ruchlemer Israel 14 167 0.6× 360 1.9× 139 1.0× 139 1.0× 50 0.5× 48 733
XX Du United States 11 262 0.9× 68 0.4× 297 2.0× 374 2.7× 194 1.8× 18 790
Leopold Oehler Austria 13 192 0.7× 115 0.6× 173 1.2× 357 2.5× 154 1.4× 21 762
B J Clarke United States 13 404 1.4× 216 1.1× 107 0.7× 171 1.2× 108 1.0× 24 814

Countries citing papers authored by Roy Baynes

Since Specialization
Citations

This map shows the geographic impact of Roy Baynes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roy Baynes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roy Baynes more than expected).

Fields of papers citing papers by Roy Baynes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roy Baynes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roy Baynes. The network helps show where Roy Baynes may publish in the future.

Co-authorship network of co-authors of Roy Baynes

This figure shows the co-authorship network connecting the top 25 collaborators of Roy Baynes. A scholar is included among the top collaborators of Roy Baynes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roy Baynes. Roy Baynes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Baynes, Roy. (2024). The future of combination therapies in I-O: insights, challenges, & future endeavors. 5(1). 1–6. 1 indexed citations
2.
Wood, Gary S., Janet Poulik, Roy Baynes, et al.. (2008). High-dose Chemotherapy and Adoptive Immunotherapy in the Treatment of Recurrent Pediatric Brain Tumors. Neuropediatrics. 39(3). 151–156. 21 indexed citations
3.
Peres, Edward, Polly E. Kintzel, Roger Dansey, et al.. (2008). Early intervention with antithrombin III therapy to prevent progression of hepatic venoocclusive disease. Blood Coagulation & Fibrinolysis. 19(3). 203–207. 24 indexed citations
4.
Chandrasekar, Pranatharthi, George Alangaden, Geetha Chalasani, et al.. (2001). Low Infectious Morbidity after Intensive Chemotherapy and Autologous Peripheral Blood Progenitor Cell Transplantation in the Outpatient Setting for Women with Breast Cancer. Clinical Infectious Diseases. 32(4). 546–551. 15 indexed citations
5.
Negrin, Robert S., K Atkinson, Tom Leemhuis, et al.. (2000). Transplantation of highly purified CD34+Thy-1+ hematopoietic stem cells in patients with metastatic breast cancer. Biology of Blood and Marrow Transplantation. 6(3). 262–271. 118 indexed citations
6.
Galy, Anne, et al.. (2000). Recovery of lymphocyte and dendritic cell subsets after autologous CD34+ cell transplantation. Bone Marrow Transplantation. 25(12). 1249–1255. 24 indexed citations
8.
Du, Wei, Roger Dansey, Roy Baynes, et al.. (1998). Successful allogeneic bone marrow transplantation in selected patients over 50 years of age – a single institution’s experience. Bone Marrow Transplantation. 21(10). 1043–1047. 27 indexed citations
9.
Cook, J. D., et al.. (1996). The use of the serum transferrin receptor for the assessment of iron status.. 49–58. 10 indexed citations
10.
Baynes, Roy. (1994). American Society of Hematology meeting. The Lancet. 344(8939-8940). 1762–1763. 11 indexed citations
11.
Baynes, Roy. (1994). Circulating transferrin receptors and assessment of iron status. The Journal of Nutritional Biochemistry. 5(7). 322–330. 44 indexed citations
12.
Kallenbach, J, et al.. (1992). Persistent neutrophil activation in mild asthma. Journal of Allergy and Clinical Immunology. 90(2). 272–274. 21 indexed citations
13.
Meyer, Tim, Roy Baynes, T. H. Bothwell, et al.. (1990). Phenotypic expression of the HLA linked iron‐loading gene in males over the age of 40 years: a population study using serial serum ferritin estimations. Journal of Internal Medicine. 227(6). 397–406. 18 indexed citations
14.
Chetty, N, et al.. (1988). Platelet aggregations, fatty acids, clotting factors and serum lipids in rural and urban blacks, and urban whites in South Africa.. PubMed. 15(5). 234–49. 6 indexed citations
15.
Baynes, Roy, B Friedman, Lynne McNamara, et al.. (1988). Transferrin iron interactions with cultured hepatocellular carcinoma cells (PLC/PRF/5).. PubMed. 46(2). 282–8. 6 indexed citations
16.
Baynes, Roy, Gail Bukofzer, T. H. Bothwell, W. R. Bezwoda, & B Macfarlane. (1987). Transferrin receptors and transferrin iron uptake by cultured human blood monocytes.. PubMed. 43(3). 372–6. 20 indexed citations
17.
MacPhail, Patrick, et al.. (1987). The fate of intravenously administered hepatic ferritin in normal, phenylhydrazine‐treated and scorbutic guinea‐pigs. British Journal of Haematology. 65(2). 239–243. 4 indexed citations
18.
Baynes, Roy, et al.. (1986). The non-immune inflammatory response: Serial changes in plasma iron, iron-binding capacity, lactoferrin, ferritin and C-reactive protein. Scandinavian Journal of Clinical and Laboratory Investigation. 46(7). 695–704. 114 indexed citations
19.
Lewis, Michael, J Kallenbach, Howard P. Levy, et al.. (1985). Severe deficiency of alpha1-antitrypsin associated with cutaneous vasculitis, rapidly progressive glomerulonephritis, and colitis. The American Journal of Medicine. 79(4). 489–494. 40 indexed citations
20.
Bezwoda, W. R., D. P. Derman, T. H. Bothwell, et al.. (1985). Serum ferritin and Hodgkin's disease. Scandinavian Journal of Haematology. 35(5). 505–510. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026